Jenna Cohen | executive |
Kathryn Haviland | executive |
Philina Lee | executive |
Christina Rossi | executive |
Michael Landsittel | executive |
Dane Leone | analyst |
Eun Yang | analyst |
Bradley Canino | analyst |
Reni Benjamin | analyst |
Salveen Richter | analyst |
Becker Hewes | executive |
Michael Schmidt | analyst |
Derek Archila | analyst |
Ami Fadia | analyst |
Michael Ulz | analyst |
Benjamin Paluch | analyst |
Peter Lawson | analyst |
David Lebowitz | analyst |
Christopher Raymond | analyst |
Matthew Biegler | analyst |
Good morning. My name is Elliot, and I will be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] I'll now turn it over to Jenna Cohen, Vice President of Investor Relations.
Thank you, Elliott, and good morning, everyone.